To explore the clinical significance of DUSP9 in HNSCC, we analyzed the relative expression of DUSP9 in HNSCC patients from TCGA data source, which currently comprises 522 tumor samples and 44 normal or paratumor samples. This evidence concerns the gene DUSP9 and head and neck squamous cell carcinoma.